Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Fine Biotech, operating under the brand name FineTest, is a global biotechnology company specializing in the production and supply of high-quality research reagents. Based in Wuhan, China, the company offers an extensive catalog of over 7,000 ELISA kits, 10,000 antibodies, and a wide array of recombinant proteins. Their products support scientific research across various disciplines, including oncology, immunology, neuroscience, and metabolism. FineTest is ISO 9001:2015 certified and provides custom services such as protein expression, antibody production, and peptide synthesis. The company serves a global clientele including academic institutions, pharmaceutical companies, and diagnostic laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Fine Biotech.